| Name | Title | Contact Details |
|---|
Today`s busy consumers often feel they don`t have time to buy lottery tickets. That`s why Linq3 provides a faster, more convenient and secure way to play and win on-the-go. Our innovative technology creates an immediate playing experience that engages the consumer – right at the point of sale. Lotteries reach more players, and retailers realize more revenue. Linq3: More players. More opportunity. Founded in 2007, we have offices in Long Beach, New York, and Atlanta. We are building products that require intense attention to detail. Our systems` core characteristics are Security, Reliability, and Scalability, and we are looking for people who not only understand these concepts, but also adhere to them. Our people are technical junkies who love what they do. Using our industry knowledge, security expertise and technology capabilities, we can build new business and develop solutions to help clients: • Increase revenues in existing markets. • Improve operational performance. • Deliver their products effectively and efficiently. What distinguishes Linq3 in the marketplace? • Technology innovation and implementation. • Research and development capabilities. • Proven and experienced management team. • Commitment to the long-term development of our solutions. Contact a team member to find out more about our growing company!
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
We have expertise in politics, non-profits, labor organizations and enterprise solutions. No matter your data challenge, TargetSmart can provide solutions driven by our experience.
The LumenVox Technology Stack provides full speech & voice biometrics capabilities to transform and power the conversational AI customer experience.
Avantix is a El Cajon, CA-based company in the Software and Internet sector.